Caraco Pharmaceutical Laboratories Ltd. (Caraco) has recalled numerous drugs at the request of the U.S. Food & Drug Administration because of the companies failure to meet the FDA’s current Good Manufacturing Practice (cGMP) requirements. The FDA originally learned that Caraco was manufacturing double thickness pills, which may lead to patients to unintentionally suffer from an overdose and/or death.
Caraco Recall List
Allopurinol Tablets
Amlodipine Tablets
Atenolol Tablets
Baclofen Tablets
Carvedilol Tablets
Cetirizine Tablets
Cetirizine IR Tablets
Choline Magnesium Trisalicylate Tablets
Citalopram HBR Tablets
Clonazepam Tablets
Clozapine Tablets
Digoxin Tablets
Flurbiprofen Tablets
Glipizide Tablets
Glipizide/Metformin Tablets
Hydrochlorothiazide Tablets
Meloxicam Tablets
Meperidine HCl C-II Tablets
Metformin Tablets
Methimazole Tablets
Metoprolol Tartrate Tablets
Midrin Capsules
Mirtazapine Tablets
Oxaprozin Tablets
Paromomycin Sulfate, USP Capsules
Paroxetine Tablets
Phentermine HCl Tablets
Ticlopidine HCl Tablets
Tizanidine HCl Tablets
Tramadol HCl Tablets
Tramadol HCl/Acetaminophen Tablets
Zolpidem Tartrate Tablets